Co‐Expression of Tardive Dyskinesia and Drug‐Induced Parkinsonism in Rats Chronically Treated With Haloperidol
Neuropsychopharmacology Reports · 2025
DOI: 10.1002/npr2.12524 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neuropsychopharmacology Reports, 2025. Verfasst von Iku Kinoshita und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Hirosaki University Graduate School of Medicine, Hirosaki, Japan. Hauptthemen laut MEDLINE: Haloperidol, Tardive Dyskinesia, Disease Models, Animal, Parkinsonian Disorders. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science, Sumitomo pharma co, Ltd..
Abstract (Originalsprache)
Aim
We aimed to create a rat model of drug‐induced parkinsonism and tardive dyskinesia by chronic administration of haloperidol and examine the expression of direct and indirect pathway markers in the striatum of the model rats.
Methods
We treated 21 rats, 14 with haloperidol decanoate and 7 with placebo. The number of vacuous chewing movements per 2 min was counted, and haloperidol‐treated rats were classified into two groups: mild and severe tardive dyskinesia. Other behavioral analyses were also conducted. After a 6‐month treatment period, rat brains were removed, and protein expression was evaluated by Western blotting.
Results
All haloperidol‐treated rats exhibited vacuous chewing movements. The frequency of exploratory behavior and rotarod test performance was lower in the mild and severe tardive dyskinesia groups. The number of vacuous chewing movements and frequency of exploratory behavior were positively correlated in haloperidol‐treated rats. The expression of dynorphin, a direct pathway marker, decreased in the severe tardive dyskinesia group. The expression of enkephalin, an indirect pathway marker, decreased both in the mild and severe tardive dyskinesia groups. The expression of dopamine D1 and D2 receptors also decreased with haloperidol treatment.
Conclusion
Both direct and indirect pathways are involved in haloperidol‐induced movement disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Hirosaki University Graduate School of Medicine, Hirosaki, Japan.
- Department of Neurology, Hirosaki University Hospital, Hirosaki, Japan.
- Department of Neurophysiology, Hirosaki University Graduate School of Medicine, Hirosaki, Japan.
ORCID-Profile: Haruo Nishijima
Förderung
- Japan Society for the Promotion of Science
- Sumitomo pharma co, Ltd.
Zitieren
APA
Kinoshita, I., Nishijima, H., Nakamura, T., Kon, T., Shimoyama, S., Hikichi, H., Suzuki, C., & Tomiyama, M. (2025). Co‐Expression of Tardive Dyskinesia and Drug‐Induced Parkinsonism in Rats Chronically Treated With Haloperidol. Neuropsychopharmacology Reports. https://doi.org/10.1002/npr2.12524
Vancouver
Kinoshita I, Nishijima H, Nakamura T, Kon T, Shimoyama S, Hikichi H, et al. Co‐Expression of Tardive Dyskinesia and Drug‐Induced Parkinsonism in Rats Chronically Treated With Haloperidol. Neuropsychopharmacology Reports. 2025. doi:10.1002/npr2.12524
BibTeX
@article{Kinoshita2025,
author = {Kinoshita, Iku and Nishijima, Haruo and Nakamura, Takashi and Kon, Tomoya and Shimoyama, Shuji and Hikichi, Hiroki and Suzuki, Chieko and Tomiyama, Masahiko},
title = {Co‐Expression of Tardive Dyskinesia and Drug‐Induced Parkinsonism in Rats Chronically Treated With Haloperidol},
journal = {Neuropsychopharmacology Reports},
year = {2025},
doi = {10.1002/npr2.12524}
}
EUVIMED